Avalo Therapeutics (NasdaqCM:AVTX) FY Conference September 09, 2025 02:30 PM ET Company ParticipantsGarry Neil - CEOConference Call ParticipantsDaniel Smith - AnalystDaniel SmithGood afternoon, everyone, and thank you for joining Day Two of the H.C. Wainwright 27th Annual Global Investment Conference 2025. My name is Daniel Smith, and I'm an H.C. Wainwright Equity Research Associate in Biotechnology. With that said, let me introduce our presenter for the session. I'd like to welcome Dr. Garry Neil, CEO of A ...